Amsterdam-based Philips (NYSE: PHG) announced Monday it has agreed to purchase U.S.-based Genlyte (NASDAQ: GLYT) group for $2.7 billion.
The deal values Genlyte at about $95.70 per share, or about a 50% premium over Genlyte's Friday closing price. Genlyte's shares surged $31.50 (just over 50%) to $94.17 in Monday morning trading. Philips gained 24 cents to $42.46.
Philips said the deal will strengthen its position in energy-efficient lighting, adding that with Genlyte it will surpass rival General Electric (NYSE: GE) as the largest lighting company in North America. GE's shares fell 14 cents to $37.53.
Stock Analysis: It looks like Philips has executed a smart purchase at a fair price. In Genlyte, Philips will gain greater access to U.S. distributors, which will increase sales of its fluorescent and next-generation light-emitting diode (LED), energy-saving light bulbs. The deal will also add to Philips's manufacturing capacity. Philips has the light bulb / lighting lead in Europe, but (understandably) it trails GE in North America. Hence the Genlyte deal underscores its commitment to compete on both continents with GE, as the market for energy-efficient lighting expands at a healthy rate in the years ahead.
Last updated: February 09, 2012: 11:33 AM
Hot Stocks
DailyFinance Headlines
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
Benzinga Headlines
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
- CVS Profit Up as Walgreen's Customers Defect
TheFlyOnTheWall.com Headlines
- DOJ announces $25B settlement with five largest mortgage servicers
- Apple to unveil iPad 3 in first week of March, All Things D says
- On The Fly: Analyst Initiation Summary
- On The Fly: Analyst Downgrade Summary
- On The Fly: Analyst Upgrade Summary
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

